![Bo Rode Hansen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bo Rode Hansen
Directeur Général chez Genevant Sciences Corp.
Provenance du réseau au premier degré de Bo Rode Hansen
Entité | Type d'entité | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 10 | |
Genevant Sciences Corp.
![]() Genevant Sciences Corp. Pharmaceuticals: MajorHealth Technology Part of Roivant Sciences Ltd., Genevant Sciences Corp. operates as a Canadian biopharmaceutical company. The company is based in Burnaby, Canada. The CEO of the company is Bo Rode Hansen.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
LIfT BioSciences Ltd.
![]() LIfT BioSciences Ltd. Miscellaneous Commercial ServicesCommercial Services LIfT BioSciences Ltd. is a pre-clinical stage biotech company based in Brighton, UK. LIfT BioSciences is developing a first-in-class alpha neutrophil cell therapy called N-Lift, which is produced from a patented process using exceptional stem cells, a proprietary enhancement media, and genetic engineering. The therapy is designed to destroy solid tumors both directly and indirectly by turning the tumor microenvironment against the tumor and recruiting the rest of the immune system to destroy it. The British company is working with a range of pharmaceutical license partners across oncology, immunology, neurology, and AMR to develop a portfolio of immune-modulatory alpha neutrophils for treating a range of therapeutic indications, including solid tumors. The company's goal is to deliver complete remission in high unmet need solid tumors before the decade is out. The company was founded in 2014 by Alexander William Blyth, who was inspired to create the company after his mother passed away from pancreatic cancer.
4
| Holding Company | Miscellaneous Commercial Services | 4 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Bo Rode Hansen via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ARBUTUS BIOPHARMA CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Chairman Chief Executive Officer | |
University of Copenhagen | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
Copenhagen Business School | College/University | Graduate Degree Graduate Degree | |
American Society of Gene & Cell Therapy
![]() American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services The American Society of Gene & Cell Therapy is a medical and professional organization that represents researchers and scientists devoted to the discovery of gene and cell therapies. The American company was founded by Mark A. Kay. | Miscellaneous Commercial Services | Founder | |
Sapiens Denmark A/S
![]() Sapiens Denmark A/S Packaged SoftwareTechnology Services Tia Technology A/S develops software applications for insurance industry. It also offers administration, claims, handling, life and pension, as well as country functionality services. The company was founded by Peter Schrøder, Hans Agerlin Petersen, and Lars Lorentzen on May 1, 1997 and is headquartered in Virum, Denmark. | Packaged Software | Director of Finance/CFO | |
Mckinsey & Co. Denmark P/S
![]() Mckinsey & Co. Denmark P/S Miscellaneous Commercial ServicesCommercial Services Part of McKinsey & Co., Inc., Mckinsey & Co. Denmark P/S is a Danish company that provides business and other management consultancy services. The company is based in Copenhagen, Denmark. | Miscellaneous Commercial Services | Chairman | |
Edvince AB
![]() Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Biotechnology | Director/Board Member | |
IMMUNOVIA AB | Pharmaceuticals: Major | Director/Board Member | |
Rehaler ApS
![]() Rehaler ApS Medical SpecialtiesHealth Technology Rehaler ApS develops medical devices for the treatment of migraine. | Medical Specialties | Director/Board Member | |
Case Western Reserve University
![]() Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Doctorate Degree | |
GENMAB A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Wageningen University | College/University | Graduate Degree | |
University of Utrecht | College/University | Doctorate Degree | |
TME PHARMA N.V. | Biotechnology | Director/Board Member | |
Immagene BV
![]() Immagene BV Pharmaceuticals: MajorHealth Technology Immagene BV is a private biotech company based in the Netherlands that is dedicated to developing next-generation precision immuno-oncology treatments. Immagene is committed to transforming cancer treatment and has a focus on precision medicine. The Dutch company was founded on world-leading research from the Netherlands Cancer Institute and drug R & D expertise from industry veterans. The company was founded by Maarten Ligtenberg, Christian Blank, and Daniel Peeper, with Maarten Ligtenberg serving as the CEO since incorporation. | Pharmaceuticals: Major | Director/Board Member | |
Hollandbio | Director/Board Member | ||
LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder | |
VOYAGER THERAPEUTICS, INC. | Biotechnology | Founder | |
Michigan State University | College/University | Undergraduate Degree | |
Vaximm AG
![]() Vaximm AG Miscellaneous Commercial ServicesCommercial Services Vaximm AG provides active immunotherapies for patients suffering from cancer. It develops and provides vaccines for patients suffering from cancer. The firmalso provides research, development, manufacture, marketing and sale of pharmaceutical products. The company was founded in September 2008 and is headquartered in Basel, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Jomed AG | Corporate Officer/Principal | ||
University of Basel | College/University | Graduate Degree | |
University of St. Gallen | College/University | Masters Business Admin | |
APEIRON Biologics AG
![]() APEIRON Biologics AG BiotechnologyHealth Technology APEIRON Biologics AG operates as a clinical-stage company which engages in the discovery and development of novel cancer immunotherapies. The firm develops APN311, a therapeutic antibody to treat pediatric patients with neuroblastoma; APN301, an immunocytokine consisting of a humanized antibody genetically linked to two human IL-2 molecules; and APN401, a first-in-class autologous cellular therapy. The company was founded by Josef Penninger in 2005 and is headquartered in Vienna, Austria. | Biotechnology | Corporate Officer/Principal | |
Miracor Medical SA
![]() Miracor Medical SA Electronic Equipment/InstrumentsElectronic Technology Miracor Medical SA engages in the development and manufacture of medical devices. Its product PICSO (Pressure-controlled Intermittent Coronary Sinus Occlusion) Impulse System has a driving console and associated catheters to improve outcomes for severe heart attack patients. It seeks to increase blood flow to the affected heart tissue, thereby improving the overall heart function after a heart attack. The company was founded by Werner Mohl in May, 2008 and is headquartered in Vienna, Austria. | Electronic Equipment/Instruments | Director/Board Member | |
BC Platforms AG
![]() BC Platforms AG Data Processing ServicesTechnology Services BC Platforms AG provides powerful genomic data management and analysis solutions. It offers pharmaceutical, biobank, healthcare and academia products. The company was founded by Timo Kanninen in 1997 and is headquartered in Basel, Switzerland. | Data Processing Services | Director/Board Member | |
Stanford University School of Medicine | College/University | Corporate Officer/Principal | |
JFG Life Sciences Stiftung der Universität Basel
![]() JFG Life Sciences Stiftung der Universität Basel Investment Trusts/Mutual FundsMiscellaneous JFG Life Sciences Stiftung der Universität Basel engages in the promotion of innovation transfer in the field of life sciences and related areas. It also supports knowledge and technology transfer at the University of Basel. The company was founded on December 20, 2018 and is headquartered Basel, Switzerland. | Investment Trusts/Mutual Funds | Chief Executive Officer | |
Revel Pharmaceuticals, Inc.
![]() Revel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Revel Pharmaceuticals, Inc. engages in the provision of therapeutic designer enzymes to degrade molecular damage that accumulates with aging. The company was founded by Aaron Cravens, David Spiegel and Jason Crawford in 2019 and is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Kizoo Technology Capital GmbH
![]() Kizoo Technology Capital GmbH Investment ManagersFinance Kizoo Technology Capital GmbH (KIZOO) is the venture capital arm of Atevia AG, itself a subsidiary of Cinetic Gesellschaft zur Entwicklung & Vertrieb von Medien. The firm was founded by Michael Greve, Matthias Hornberger, and Frank Schüler in 2006. It is headquartered in Karlsruhe, Germany. | Investment Managers | Private Equity Investor | |
MOLOGEN AG | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
The American University of Rome | College/University | Doctorate Degree | |
Glycotope GmbH
![]() Glycotope GmbH BiotechnologyHealth Technology Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany. | Biotechnology | Chief Executive Officer | |
Bech-Bruun Advokatpartnerselskab
![]() Bech-Bruun Advokatpartnerselskab Miscellaneous Commercial ServicesCommercial Services Bech-Bruun Advokatpartnerselskab is a Danish company that provides legal services. The private company is based in Copenhagen, Denmark. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Southern Denmark | College/University | Corporate Officer/Principal | |
Kt Stålindustri A/S | Chairman | ||
Everclassic ApS
![]() Everclassic ApS Catalog/Specialty DistributionRetail Trade Everclassic ApS operates an online global marketplace for vintage furniture, home designs, and art objects. It offers a wide range of designs on lighting, furniture, ceramics, and stoneware. The company was founded by Jacob Kam, Christian Rasmus Warnke Nørregaard-Madsen, and Peter Kam in 2012 and is headquartered in Copenhagen, Denmark. | Catalog/Specialty Distribution | Director/Board Member | |
Aids United | Director/Board Member | ||
PHARMA EQUITY GROUP A/S | Real Estate Development | Chairman | |
H. LUNDBECK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
Roche Pharma (Schweiz) AG
![]() Roche Pharma (Schweiz) AG Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharma (Schweiz) AG is a Swiss pharmaceutical company that develops innovative medicines in key therapeutic areas. The company is based in Basel, Switzerland. The company translates scientific excellence into advanced medicines that help patients. | Medical Distributors | Corporate Officer/Principal | |
University of Manchester Institute of Science & Technology | College/University | Undergraduate Degree | |
ViiV Healthcare Ltd.
![]() ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | President | |
International Partnership for Microbicides
![]() International Partnership for Microbicides BiotechnologyHealth Technology The International Partnership for Microbicides develops products for the prevention of human immunodeficiency virus. The private company is based in Silver Spring, MD. | Biotechnology | Director/Board Member | |
Glaxowellcom | Corporate Officer/Principal | ||
Repoceuticals A/S | Director/Board Member |
Statistiques
Internationale
Danemark | 15 |
Etats-Unis | 13 |
Suisse | 9 |
Pays-Bas | 5 |
Allemagne | 5 |
Sectorielle
Health Technology | 19 |
Consumer Services | 13 |
Commercial Services | 6 |
Technology Services | 3 |
Finance | 3 |
Opérationnelle
Director/Board Member | 78 |
Corporate Officer/Principal | 26 |
Chairman | 20 |
Chief Executive Officer | 13 |
Independent Dir/Board Member | 12 |
Relations les plus connectées
- Bourse
- Insiders
- Bo Rode Hansen
- Connexions Sociétés